
This ‘vegan’ snack is being recalled for containing an ingredient that’s not vegan
A snack marketed as ‘vegan’ is being recalled for containing an undeclared animal ingredient.
Browse recent medication, recall, and health-related stories.
Page 10 of 51

A snack marketed as ‘vegan’ is being recalled for containing an undeclared animal ingredient.

The chlorthalidone recall is Class II, not Class I. How to check lot RISA24002, what failed dissolution means, and why patients should not stop.
Studies link shingles to higher risks of stroke and heart events, especially soon after infection
Hard-to-detect synthetic opioids evade fentanyl test strips, toxicologist warns WTOP News MSU health officials warn campus about dangerous synthetic opioid WILX New potent street drug prompts Hawaii health alert Hawaii News Now What to know about cychlorphine, a new synthetic opioid raising alarm WRAL Drug 10 times stronger than fentanyl claiming lives in the US newatlas.com

Dr. K. S. Somasekhar Rao, Sr.Consultant Medical Gastroenterologist & Hepatologist. Clinical Director, Yashoda Hospitals, Hitec City Hyderabad.says,

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.
This World Heart Day, the World Heart Federation's global campaign carries a simple message: Don't Miss a Beat! It's a warning about hidden symptoms such as the fatigue dismissed as overwork, the breathlessness blamed on fitness, the chest tightness written...

A hospital in the UK has restricted visiting amid an ongoing scabies outbreak that has been affecting the community for months
Victorian disease rips through UK town forcing hospital wards to close Daily Express Scabies outbreak at hospital closes wards BBC Visitors banned from Llanelli hospital as scabies outbreak worsens Wales Online Outbreak of 'nightmare' Victorian disease at UK hospital CLOSES wards The Sun Eight-legged parasite that lays EGGS under your skin are on rise in UK - as hospital ward forced to close The Irish Sun

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], September 30: Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. ("PPL") (NSE: PPLPHARMA) (BSE: 543635), today announced that its Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government through the Life Sciences Scale-Up Fund (LSSUF), enabling PPS to upgrade site infrastructure and commercialize Ontario-made health technologies for new markets.
Hard-to-detect synthetic opioids evade fentanyl test strips, toxicologist warns WTOP News MSU health officials warn campus about dangerous synthetic opioid WILX New potent street drug prompts Hawaii health alert Hawaii News Now What to know about cychlorphine, a new synthetic opioid raising alarm WRAL Drug 10 times stronger than fentanyl claiming lives in the US newatlas.com
This World Heart Day, the World Heart Federation's global campaign carries a simple message: Don't Miss a Beat! It's a warning about hidden symptoms such as the fatigue dismissed as overwork, the breathlessness blamed on fitness, the chest tightness written...
Victorian disease rips through UK town forcing hospital wards to close Daily Express Scabies outbreak at hospital closes wards BBC Visitors banned from Llanelli hospital as scabies outbreak worsens Wales Online Outbreak of 'nightmare' Victorian disease at UK hospital CLOSES wards The Sun Eight-legged parasite that lays EGGS under your skin are on rise in UK - as hospital ward forced to close The Irish Sun

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], September 30: Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. ("PPL") (NSE: PPLPHARMA) (BSE: 543635), today announced that its Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government through the Life Sciences Scale-Up Fund (LSSUF), enabling PPS to upgrade site infrastructure and commercialize Ontario-made health technologies for new markets.